ArticleMedComm2024

SCR-7952, a highly selective MAT2A inhibitor, demonstrates synergistic antitumor activities in combination with the

Zhiyong Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.